Tom Burgess

In this engaging discussion, Tom Burgess, an FT investigations correspondent known for his incisive reporting, dives into the controversy surrounding Eli Lilly's urgent request for Covid-19 antibody approval. He also unpacks the Vatican's dubious investment in derivatives, questioning the morality behind using charity funds. Most chillingly, he investigates the mysterious deaths of two potential witnesses linked to a high-stakes mining corruption case, shedding light on the dark underbelly of corporate misconduct and the risks faced by whistleblowers.